Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications
1,4,5,8,10,13,3,19,20,21,22,24,25,27,28,29,30,31,33,34,35,36,37,38,39,40,41,42,43,44,47,48,51,52,54,55,56,57,58,59,53,60,62,65,66,67,68,69,70,71,73,74,75,45,78,80,81,82,83,86,87,89,90,6,94,98,99,101,102,104,105,106,107,108,110,112,113,114,116,117,118,119,120,121,122,123,124,125,49,128,109,130,132,133,135,136,138,139,140,141,144,145,146,14,148,150,151,152,153,154,155,157,159,160,162,164,165,169,171,174,175,179,180,181,184,185,188,190,191,163,192,194,161,195,197,198,201,2,203,208,209,213,215,216,219,220,222,224,225,227,229,230,232,233,234,235,239,241,242,245,134,63,249,253,32,258,262,266,26,271,276,12,294
DOI: https://doi.org/10.1101/2023.03.31.23287839
2023-03-31
MedRxiv
Abstract:Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes. To characterise the genetic contribution to these processes across ancestry groups, we aggregate genome-wide association study (GWAS) data from 2,535,601 individuals (39.7% non-European ancestry), including 428,452 T2D cases. We identify 1,289 independent association signals at genome-wide significance (P<5×10-8) that map to 611 loci, of which 145 loci are previously unreported. We define eight non-overlapping clusters of T2D signals characterised by distinct profiles of cardiometabolic trait associations. These clusters are differentially enriched for cell-type specific regions of open chromatin, including pancreatic islets, adipocytes, endothelial, and enteroendocrine cells. We build cluster-specific partitioned genetic risk scores (GRS) in an additional 137,559 individuals of diverse ancestry, including 10,159 T2D cases, and test their association with T2D-related vascular outcomes. Cluster-specific partitioned GRS are more strongly associated with coronary artery disease and end-stage diabetic nephropathy than an overall T2D GRS across ancestry groups, highlighting the importance of obesity-related processes in the development of vascular outcomes. Our findings demonstrate the value of integrating multi-ancestry GWAS with single-cell epigenomics to disentangle the aetiological heterogeneity driving the development and progression of T2D, which may offer a route to optimise global access to genetically-informed diabetes care.